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Abstract
Background: During adrenergic stress, the influence of age on left atrial (LA) function is
unknown. We hypothesized that aging decreases LA total emptying fraction (LAEF) during
maximal adrenergic stress. The aim of the study was to determine the influence of aging on LA
function during adrenergic stress in middle aged and older patients.
Methods: We enrolled 167 middle aged and elderly participants, and measured LA and left
ventricular (LV) volumes using a multi-slice three-dimensional cine white blood cardiovascular
magnetic resonance (CMR) technique before and during intravenous dobutamine infused to
achieve 80% of the maximum heart rate response for age. Paired sample t-test was used to
detect differences in LA and LV volumes between baseline and peak dose stage of dobutamine
stress CMR, and multivariable linear regression was used to identify predictors of LA function.
Results: Participants averaged 68 ± 8 years in age, 53% were men, 25% exhibited coronary
artery disease, 35% had diabetes, 9% had a remote history of atrial fibrillation, 90% had
hypertension, and 11% had inducible LV wall motion abnormalities indicative of ischemia
during dobutamine CMR. Increasing age correlated with LA volumes (maximal and minimal)
and inversely correlated with LAEF at rest and after peak adrenergic stress. Age was an indepen-
dent predictor of LAEF during adrenergic stress, even after accounting for gender, LV volu-
mes, and other co-morbidities including inducible ischemia.
Conclusions: Age is associated with a decrease in LA function during adrenergic stress even
after adjusting for co-morbidities associated with cardiovascular disease and LV function.
(Cardiol J 2012; 19, 1: 45–52)
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Introduction
Aging is associated with cardiovascular remo-
deling [1]. Left atrial (LA) size and volumes increase
with age, leading to an increase in the ratio of LA/
/left ventricular (LV) volume [2–4]. Relative to
younger individuals, older individuals often depend
more on active LA contraction rather than passive
LA conduit function to fill the LV during diastole at
rest [5].
To date, however, the effect of aging on LA
performance during adrenergic stress has not been
described. Studies that have measured LA size and
volumes at rest have shown that abnormalities of
resting LA volume and size forecast adverse car-
diovascular outcomes including heart failure (HF)
and poor exercise capacity [6–10].
We hypothesized that aging decreases LA per-
formance in response to adrenergic stress in mid-
dle aged and older patients. Adrenergic stimulation
is a major mediator of the cardiovascular response
to exercise. Accordingly, the aim of this study was
to determine the influence of aging on LA perfor-
mance during adrenergic stress. To address this
aim, we measured LA volumes during dobutamine
stress in elderly individuals using three-dimensio-
nal cardiac magnetic resonance imaging (DCMR).
We sought to determine the association of age and
adrenergic change in LA performance after account-
ing for other co-morbidities known to influence LA
function including LV performance and the pre-
sence of inducible ischemia [11].
Methods
Study population
Our study was approved by the Institutional
Review Board at the Wake Forest University School
of Medicine, and all participants provided informed
consent. Participants were enrolled for DCMR as part
of the National Institutes of Health R01HL076438
entitled ‘Pulmonary Edema and Stiffness of the
Vascular System (PREDICT)’. PREDICT is a 550
person longitudinal cohort study designed to iden-
tify abnormalities of the cardiovascular system that
forecast HF in middle aged and elderly individuals
who have yet to experience HF. The study is in the
early recruitment phase, and longitudinal follow-up
has yet to occur.
The inclusion criteria for PREDICT are: age
between 55 and 85 years; left ventricular ejection
fraction (LVEF) > 45%; diabetes with a fasting glu-
cose ≥ 126 mg/dL or treatment > 5 years; and/or
hypertension defined as a systolic blood pressure
(SBP) > 140 mm Hg, a diastolic blood pressure
(DBP) > 85 mm Hg or receipt of antihypertensive
therapy > 5 years; and/or the presence of coronary
artery disease (CAD). Participants in PREDICT are
identified from the community through the recruit-
ment core of the Claude Pepper Center on Aging at
the Wake Forest University School of Medicine.
Eligible candidates are identified through established
lines of communication that include paid advertising,
mass mailing and community group presentations to
a population from seven states within parts of rural
Virginia, West Virginia, Tennessee, Kentucky, South
Carolina, Georgia, and western North Carolina.
Participants with contraindications to DCMR,
atrial fibrillation (AF) at the time of image acquisi-
tion, mitral regurgitation or mitral stenosis of great-
er than mild severity are excluded from participa-
tion. The present study utilizes data from the first
167 individuals consecutively enrolled into the
PREDICT study, with images collected at rest and
peak dose of dobutamine stress. The study is regi-
stered with clinicaltrials.gov (NCT00542503).
Study design
Upon recruitment, baseline clinical factors such
as diabetes mellitus, hypertension, CAD, AF, age,
and gender were collected according to previously
published techniques [12]. Each person underwent
DCMR on a 1.5T Avanto scanner (Siemens Medi-
cal Solutions, Erlangen, Germany). Using steady-
state free precession cine imaging, a multi-slice,
multiphase stack of short axis images of both LA
and LV volumes were obtained in a single breath-
hold. Imaging parameters for both LA and LV volu-
mes included a 40 × 24 cm field of view, a 6 mm
thick slice thickness, a 55 ms repetition time (TR),
a 2.3 ms echo-time (TE), a 192 × 109 matrix,
k-space segmentation with 24 views per segment,
1,500 Hz/pixel bandwidth, and parallel imaging with
an acceleration factor of 3. Typically, 16 cine frames
were obtained with a 40–55 ms temporal resolution,
depending on the heart rate [13, 14].
As shown in Figure 1, the maximal LA area
(bottom left panel) and minimal LA area (bottom
right panel) in mm2 were manually traced in each
slice position. The LA volumes (in mm3) were cal-
culated by summing the areas for all of the slices
within the LA and then multiplying this value by the
slice thickness (mm). This process was performed
at rest and peak stress using CAAS-MRV software
(Pie Medical Imaging, Netherlands). LA maximal
volume (LAV max) and LA minimal volume (LAV
min) were calculated in each slice from the LA base
to the mitral annulus using CAAS-MRV software
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(Pie Medical Imaging, Netherlands). Slices near the
mitral annulus were excluded from calculations if
the LA wall contained more than 50% of the circum-
ference of the LV wall within the slice.
According to previously published techniques,
[2] LAV max was defined as the largest LA volume
during the entire cardiac cycle; similarly, LAV min
was defined as the smallest LA volume during the
cardiac cycle. LA total emptying volume was de-
fined as (LAV max – LAV min) and LA total empty-
ing fraction (LAEF) was defined as (LAV max – LAV
min)/LAV max. To account for the influence of LV
function on LA performance during adrenergic
stress, we simultaneously measured LV volumes
in all the participants. According to previously pub-
lished techniques [15], LV end-diastolic volume
(LVEDV), LV end-systolic volume (LV ESV), and
LVEF were calculated using a modified Simpson’s
Rule determination.
All volumes were indexed to body surface area,
and tracings of LA and LV volumes were performed
by individuals blinded to participant identifiers as
well as assessments performed on the other heart
chamber (i.e. those performing LA calculations
were blinded to LV calculations, and vice versa).
Statistical analysis
To estimate the impact of age on LA perfor-
mance during dobutamine stress, we calculated dif-
ferences in baseline and peak dose (delta) LAEF.
Similarly, differences between baseline and peak
dose (delta) LVEF were calculated. To assess the
inter-observer variability for the measure of LA
volumes, a random sample of 20 participants was
drawn by another study team member (HC) in
a blinded fashion. Statistical analyses were per-
formed using the Statistical Program for Social Sci-
ences (version 13.0 SPSS Inc., Chicago, IL, USA).
Continuous variables are represented as mean ±
± standard deviation. Chi-square tests were used
to test association between categorical variables.
Pearson’s correlation analysis was used to find the
correlation between age, LA volumes and function
for baseline and peak dose stage of DCMR. Paired
sample t test was used to detect the differences in
LA and LV volumes, LAEF, and LVEF between
baseline and peak dose stage of DCMR. To estimate
the impact of age on LA performance during adrener-
gic stress, we performed two linear regression
models with peak dose LAEF and delta LAEF as
dependent variables. Age, gender, diabetes melli-
Figure 1. Multipanel depiction of slice positions and analysis technique used to derive left atrial (LA) volumes at
baseline and peak dose of dobutamine stress. Four-chamber view of the heart (top panel) for planning the multi-slice
short-axis series of images (green lines) used to calculate both LA and ventricular volumes. The right atrium, LA,
right ventricle (RV), and left ventricle (LV) are denoted. As shown, the maximal LA area (bottom left panel) and
minimal LA area (bottom right panel) in mm2 were manually traced in each slice position and the LA volumes in mm3
were calculated by summing the areas for all of the slices within the LA and then multiplying this value by the slice
thickness (mm).
Left atrial maximal area Left atrial minimal area
4−chamber view
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tus, hypertension, CAD, history of AF and peak
dose LVEF or delta LVEF as appropriate, were the
variables included in the regression models. Lin-
ear regression results are given by presenting the
standardized regression co-efficient (B). A two-
-sided p-value of < 0.05 was considered to be sta-
tistically significant.
Results
The demographics of the study population are
shown in Table 1. The study group was not homo-
genous. The majority of patients exhibited hyperten-
sion (90%) and 35% had diabetes (Table 1) with an
average duration of diabetes of 9.5 ± 6.8 years. The
baseline and peak dose SBP, DBP and heart rate
are shown in Table 1. The differences in mean LA
and LV volumes and function between baseline and
peak dose stage of DCMR are shown in Table 2. LA
volumes decreased and the LAEF increased with
peak dose dobutamine stress (Table 2). Similarly
LV volumes decreased with increasing stress, and
LVEF increased with stress (Table 2).
Correlations between age and
left atrium volumes and function
Increasing age correlated with LAV max at
baseline and peak dose stage of DCMR (baseline:
r = 0.26, p = 0.001, and peak dose: r = 0.23, p = 0.003).
Similarly, age correlated with LAV min (baseline:
r = 0.303, p < 0.001, and peak dose: r = 0.275,
p < 0.001). Increasing age was inversely correlat-
ed with LAEF at baseline and peak dose stage of
DCMR (baseline: r = –0.18, p = = 0.02, and peak
dose: r = –0.29, p < 0.001; Fig. 2).
Effect of baseline and peak dose blood
pressure and heart rate on left atrium
volumes and LAEF
There were significant correlations between
baseline SBP and LAV max (r = 0.24, p = 0.02), LAV
min (r = 0.22, p = 0.03), LA emptying volume
(r = 0.22, p = 0.03) but not with LAEF (r = 0.01,
p = 0.9). Baseline DBP did not correlate with LAV
max (r = –0.001, p = 0.9), LAV min (r = –0.022,
p = 0.8), LA emptying volume (r = 0.03, p = 0.7) or
LAEF (r = 0.07, p = 0.5). Baseline heart rate did
not correlate with LAV max (r = –0.17, p = 0.06),
LAV min (r = –0.17, p = 0.06), LAEF (r = –0.12,
p = 0.17) or LA emptying volume (r = 0.07, p = 0.46).
Peak dose SBP significantly correlated with
LAV max (r = 0.22, p = 0.03), and LAV min (r = 0.23,
p = 0.03), but not with LA emptying volume (r = 0.13,
p = 0.2) or LAEF (r = –0.09, p = 0.36). Peak dose
DBP significantly correlated with LAV max (r = 0.32,
p = 0.002), LAV min (r = 0.29, p = 0.006), and LA
emptying volume (r = 0.27, p = 0.01) but not with
Table 2. Mean left atrial (LA) volumes, left atrial total emptying fraction and left ventricular (LV) volumes
and left ventricular ejection fraction at baseline and peak dose dobutamine stress.
Baseline Peak dose P
Left atrium
LA maximal volume* 31 ± 9 25 ± 7 < 0.001
LA minimal volume* 18 ± 6 12 ± 5 < 0.001
LA total emptying fraction 42 ± 7 51 ± 8 < 0.001
Left ventricle
LV end-diastolic volume* 65 ± 14 50 ± 13 < 0.001
LV end-systolic volume* 29 ± 10 17 ± 8 < 0.001
LV ejection fraction 56 ± 9 67 ± 10 < 0.001
*Values indexed to body surface area





Coronary artery disease 25%
Diabetes 35%
Hypertension 90%
History of atrial fibrillation 9%
Inducible wall motion abnormalities 11%
Mean baseline SBP [mm Hg] 142±18
Mean baseline DBP [mm Hg] 81±12
Mean baseline heart rate [bpm] 65±12
Mean peak dose SBP [mm Hg] 126±22
Mean peak dose DBP [mm Hg] 72±16
Mean peak dose heart rate [bpm] 123±18
SBP —– systolic blood pressure; DBP — diastolic blood pressure
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LAEF (r = –0.04, p = 0.7). Peak dose heart rate
significantly correlated with LAV max (r = –0.29,
p = 0.001), LAV min (r = –0.334, p = 0.001), LAEF
(r = 0.257, p = 0.001) and LA emptying volume
(r = –0.13, p = 0.09)
The change in SBP (baseline SBP – peak dose
SBP) did not correlate with delta LAV max (r = 0.07,
p = 0.5), delta LAV min (r = 0.1, p = 0.3), delta LA
emptying volume (r = 0.01, p = 0.9) or delta LAEF
(r = –0.03, p = 0.8). Similarly, the change in DBP
did not correlate with delta LAV max (r = –0.06,
p = 0.55), delta LAV min (r = –0.06, p = 0.59), delta
LA emptying volume (r = –0.05, p = 0.6) or delta
LAEF (r = –0.05, p = 0.6). However, change in
heart rate (baseline heart rate – peak dose heart
rate) significantly correlated with delta LAV max
(r = –0.26, p = 0.005), LAV min (r = –0.27, p =
= 0.003), and LA emptying volume (r = –0.19, p =
= 0.04) but not with delta LAEF (r = 0.11, p = 0.24).
Effect of history of atrial fibrillation
on left atrium volumes and LAEF
Patients with prior history of AF (not during
imaging) had significantly lower baseline LAEF
(38 ± 8 vs. 42 ± 6, p = 0.03) and peak dose LAEF
(46 ± 8 vs. 51 ± 8, p = 0.02) when compared to
those without a history of AF. However, patients
with prior history of AF did not have statistically
significant lower delta LAEF (7.7 ± 7 vs. 9 ± 1,
p = 0.5) when compared to those without a history
of AF.
Regression analysis
Linear regression analysis was performed to
determine the association between age and LAEF
during adrenergic stress after adjusting for other
possible confounding factors (Table 3). Age was an
independent predictor of LAEF during peak dose
DCMR, even after adjusting for the influence of
LVEF and other co-morbidities (Table 3).
Impact of exclusion of participants
with positive stress test on the analyses
Nineteen (11%) participants had inducible LV
wall motion abnormalities indicative of ischemia
during DCMR. To exclude the possibility that in-
ducible LV wall motion abnormalities indicative of
ischemia may have confounded our results, regres-
sion analysis was conducted after exclusion of par-
ticipants who had inducible LV wall motion abnor-
malities during DCMR. After exclusion of partici-
pants with positive DCMR, age remained an
independent predictor of LAEF during peak doses
of adrenergic stress.
Inter-observer variability
A random sample of 20 participants was drawn
by another study team member (HC) in a blinded
Figure 2. Correlation between age and left atrium total emptying fraction; r = Pearson’s correlation, baseline: r = –0.18,
p = 0.02, p = 0.03 and peak dose: r = –0.29, p < 0.001.
50
Cardiology Journal 2012, Vol. 19, No. 1
www.cardiologyjournal.org
fashion. The correlation between the two measures
was very high (r = 0.91).
Impact of age on left atrium function
during dobutamine stress
After adjusting for co-morbidities and delta LVEF
(peak dose – baseline LVEF), age remained an inde-
pendent predictor of change in LA function (delta
LAEF) during adrenergic stress (Table 3). These re-
sults did not change after performing stratified analy-
ses which excluded participants with inducible wall
motion abnormalities indicative of ischemia.
Discussion
Our study is the first to demonstrate that age
is an independent predictor of LA performance
(LAEF) after catecholamine induced stress. This
finding is true even after accounting for the influ-
ence of potentially confounding clinical conditions
such as LV function or underlying hypertension,
diabetes, or CAD. These results are also the first
to describe LA function during stress using three-
dimensional imaging techniques. Breathheld LV
volumetric MRI image acquisitions have been
shown to be both highly accurate and reproducible
relative to two-dimensional techniques [16, 17]. Our
results indicate that three-dimensional LA volumet-
ric image acquisitions are feasible throughout phar-
macologic stress at relatively high heart rate, and
analyses of these images can be accomplished with
low interobserver variability.
Prior studies evaluating LA function have been
performed at rest. The findings from our baseline
or resting LA measurements (Table 2 baseline val-
ues) are consistent with these previous studies [3,
18]. With peak dose of intravenous dobutamine,
LAV min decreased. This observation is similar to
changes in LV volumes reported in other dobu-
tamine infusion studies [19–21]. Also, LAV max
(a measure of LA preload) decreased with peak dose
of intravenous dobutamine. LVEDV has also been
reported to decrease with increasing doses of in-
travenous dobutamine [19]. The results of our study
indicate that LA preload diminishes along with
LVEDV, which presumably occurs due to dimini-
shed preload at peak dobutamine.
A history of AF correlated inversely with LA
function in our study. Since we did not employ high
temporal resolution studies to measure LA function
in patients with AF, these patients were excluded
from this study. However, a history of AF did not
correlate with change in LAEF between baseline
and peak dose. Regression analysis also showed that
history of AF was not a significant predictor of peak
dose LAEF and delta LAEF when adjusted for oth-
er factors (Table 3). LV function impacts LA func-
tion by increasing its reservoir capacity during LV
systole through the downward displacement of the
mitral annulus. The LV also influences LA conduit
function by its strong suction during early LV dias-
tole [11]. As shown in Table 3, age remained an
independent predictor of LA function, even after
adjusting for the influence of LV function on LA
function during adrenergic stress.
In patients with CAD, both LVEDV and LVESV
have been shown to exhibit an abnormal increase
with high intravenous infusion rates of dobutamine
in the setting of inducible ischemia [20]. To deter-
mine whether LV ischemia influenced our observed
association between age and LA performance, we
performed stratified analyses (excluding partici-
pants with dobutamine-induced ischemia) and found
that the relationship between aging and LA perfor-
Table 3. Multivariate predictors of left atrial total emptying fraction during adrenergic stress.
Outcome Variables Peak dose Delta LAEF
B P B P
LAEF Age –0.28 < 0.001* 0.2 0.01*
Male 0.14 0.06 –0.17 0.02*
CAD 0.13 0.08 –0.09 0.27
DM 0.07 0.35 –0.113 0.16
HTN 0.16 0.04* –0.15 0.06
Prior AF 0.13 0.1 –0.003 0.97
LVEF 0.23 0.002* 0.145 0.06*
*Final independent predictors in linear regression model; LAEF — left atrial total emptying fraction; CAD — coronary artery disease; DM — diabetes
mellitus; HTN — hypertension; prior AF — prior history of atrial fibrillation; LVEF — left ventricular ejection fraction; peak dose LVEF was used in the
peak dose LAEF regression model and delta LVEF was used in the delta LAEF regression model; Delta LAEF — difference between baseline LAEF
and peak dose LAEF; B — standardized co-efficient
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mance was maintained. These results suggest that
the relationship between age and adrenergic stress
induced change in LA performance is independent
of the presence of inducible LV myocardial is-
chemia.
The results of this study could have potential
clinical implications. Abnormal LA function during
adrenergic stress could contribute to the age-relat-
ed decreases in cardiovascular function that may be
operative in syndromes such as HF with preserved
ejection fraction [1, 22, 23]. Loss of LA contribu-
tion to LV filling in older persons at risk for, or with
established, HF may lead to decompensation and
pulmonary edema or exertional dyspnea [24, 25].
Even though our study was not specifically designed
to examine this association, future studies could be
performed to determine if differences exist in LA
function during stress in healthy older individuals
compared to those with HF. Such studies could add
additional understanding of the pathophysiology of
HF in individuals in whom LVEF appears pre-
served.
There are limitations to our study. Firstly, we
used LAEF to evaluate LA function. Measures of LA
performance incorporate passive conduit as well as
active contractile components. We could not readily
differentiate between these two components in our
overall assessment of LA performance. Secondly, we
did not characterize LA tissue using a late gadolini-
um enhancement technique [26, 27]. Future studies
incorporating gadolinium contrast could identify LA
fibrosis that may contribute to LA dysfunction. Third-
ly, a disadvantage of our design is that we have little
data on completely healthy individuals. The advan-
tage of our design is that we enrolled patients with
relatively common cardiovascular co-morbidities
(e.g. hypertension or diabetes) associated with ab-
normal resting LA function, and therefore, our re-
sults are applicable to patients seen in clinical prac-
tice. Fourthly, the effect of dobutamine on LA pre-
load could not be completely ruled out. As detailed
in our results, peak dose SBP and DBP did not cor-
relate with peak dose LAEF, and the changes be-
tween baseline and peak dose SBP, DBP and heart
rate did not correlate with delta LAEF.
Conclusions
Aging reduces LA performance during adren-
ergic stress, even after accounting for the influence
of LV performance, and other co-morbid conditions.
This indicates that the LA response to adrenergic
stimulation is reduced with aging, a potentially novel
mechanism contributing to the age-related declines
in cardiovascular performance.
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